logo
Select company
Select metric
$ -48.27MEarning Before Interest & Taxes (EBIT)
VS
Market
16
Sector
36
Industry
49
History
24
$ 13.95Close
$ 3.59 - $ 14.97 52-Week Range
Ticker Information

Ticker

AVTX

Company Name

AVALO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AVALO THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AVTX - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -48.27M
3/31/2025$ 69.91M
12/31/2024$ -38.33M
9/30/2024$ -10.05M
6/30/2024$ -35.78M
3/31/2024$ -140.4M
12/31/2023$ -28.11M
9/30/2023$ -28.71M
6/30/2023$ -20.95M
3/31/2023$ -25.59M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AVALO THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -49.53M.
  • Over the past 5 years, AVALO THERAPEUTICS INC's average EBIT has been $ -47.93M.
  • The median EBIT for AVALO THERAPEUTICS INC during this period was $ -47.45M
  • AVALO THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 69.91M.
  • The lowest EBIT recorded by AVALO THERAPEUTICS INC in the same timeframe $ -140.4M

AVALO THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
COYA : COYA THERAPEUTICS INC $ -21.06MABVC : ABVC BIOPHARMA INC $ -2.8MVTGN : VISTAGEN THERAPEUTICS INC $ -55.77MRPTX : REPARE THERAPEUTICS INC $ -108.76MINO : INOVIO PHARMACEUTICALS INC $ -87.76MENTX : ENTERA BIO LTD $ -10.59MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -10.1MIBIO : IBIO INC $ -18.16MPULM : PULMATRIX INC $ -7.93MERNA : ERNEXA THERAPEUTICS INC $ -38.51M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

AVTX - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -140.4M

Minimum

Mar 31, 2024

$ 69.91M

Maximum

Mar 31, 2025

$ -47.93M

Average

$ -47.45M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M